Patents by Inventor Patricia McLean

Patricia McLean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
    Patent number: 6900182
    Abstract: Compositions comprising inositolphosphoglycans (IPGs) and ribose are disclosed, and their use in the prevention or treatment of ischaemic-reperfusion injury. This treatment increases the energy generating systems of cells by employing the mitochondrial oxidative restoration system. The use of the compositions in preserving organs for transplantation is also disclosed.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: May 31, 2005
    Assignee: Sylus Pharmaceuticals Ltd.
    Inventors: Thomas William Rademacher, Leslie Greenbaum, Patricia McLean
  • Materials and methods relating to the diagnosis and treatment of diabetes and obesity
    Patent number: 6716592
    Abstract: The diagnosis of diabetes based on the level or ratio of P- and A-type inositolphosphoglycans (IPGs) in a sample from a patient is disclosed.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: April 6, 2004
    Assignee: Rodaris Pharmaceuticals Limited
    Inventors: Thomas William Rademacher, Patricia McLean
  • Materials and methods relating to the diagnosis and treatment of diabetes and obesity
    Publication number: 20040063156
    Abstract: The diagnosis of diabetes based on the level or ratio of P- and A-type inositolphosphoglycans (IPGs) in a sample from a patient, and the use of P- and A-type IPGs or their antagonists in the treatment of diabetes is disclosed. In particular, the present invention provides treatment of IDDM or lean type II diabetes (NIDDM) with a mixture of P- and A-type mediators, and treatment of obese type II diabetes (NIDDM) with a P-type mediator and/or an A-type antagonist.
    Type: Application
    Filed: September 17, 2003
    Publication date: April 1, 2004
    Applicant: Rodaris Pharmaceuticals Limited
    Inventors: Thomas William Rademacher, Patricia McLean
  • Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
    Publication number: 20030091581
    Abstract: The present invention relates to materials and methods for the diagnosis and treatment of pre-eclampsia, and more particularly to the role of P-type inositolphosphoglycans (IPGs) in the occurrence of pre-eclampsia. Methods of diagnosing pre-eclampsia by determining the level of P-type IPGs and uses of antagonists of P-type IPGs in the treatment of pre-eclampsia are disclosed, together with a method for screening for P-type IPG antagonists.
    Type: Application
    Filed: May 8, 2002
    Publication date: May 15, 2003
    Applicant: Rodaris Pharmaceuticals Limited
    Inventors: Thomas William Rademacher, Patricia McLean
  • Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
    Patent number: 6495330
    Abstract: The present invention relates to materials and methods for the diagnosis and treatment of pre-eclampsia, and more particularly to the role of P-type inositolphosphoglycans (IPGs) in the occurrence of pre-eclampsia. Methods of diagnosing pre-eclampsia by determining the level of P-type IPGs and uses of antagonists of P-type IPGs in the treatment of pre-eclampsia are disclosed, together with a method for screening for P-type IPG antagonists.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: December 17, 2002
    Assignee: Rodaris Pharmaceuticals Limited
    Inventors: Thomas William Rademacher, Patricia McLean